JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2018, Vol. 32 ›› Issue (3): 37-41.doi: 10.6040/j.issn.1673-3770.0.2017.430

Previous Articles     Next Articles

The expression and significance of interleukin-31, and interleukin-33 and its receptor ST2, in refractory rhinosinusitis

ZHANG Liyue, LIU Jinlan, YAO Dongfang, LI Jieen   

  1. Department of OtolaryngologyHead and Neck Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China
  • Received:2017-10-18 Online:2018-05-20 Published:2018-05-20

PDF (PC)

536

Abstract: Objective To study the expression of interleukinIL-31(IL-31), and interleukin-33(IL-33)and its receptor ST2, in the nasal mucosa of patients with refractory rhinosinusitis(RRS), and to investigate their role in the pathogenesis of RRS. Methods In this study, a refractory group, an initial treatment group, and a control group were established. The hematoxylin and eosin staining method was used to observe the morphology and detect the number of eosinophils(EOS)present in the mucosal tissues. The relative levels of IL-31, IL-33, and ST2 in the tissues were detected by immunohistological examination.Quantitative fluorescence real-time polymerase chain reaction was used to detect the mRNA levels of IL-31, IL-33, and ST2, and total serum immunoglobulin E(IgE)expression in the peripheral blood. Results (1)The number of EOS in the refractory group and initial treatment group were higher than that in the control group. Further, the number of EOS in the refractory group were higher than that in the initial group. (2) On immunohistological examination, the expression levels of IL-31 and IL-33 proteins in the refractory group and the initial treatment group were higher than those in the control group. Additionally, the expression levels of both IL-31 and IL-33were higher in the refractory group than in the initial treatment group. The expression of ST2 in the refractory group and the initial treatment group was higher than that in the control group, but there was no significant difference in the expression of ST2 between the refractory group and the initial treatment group. (3) At the level of mRNA expression, the levels of IL-31 and IL-33 in the refractory group and the initial treatment group were higher than those in the control group. Furthermore, the levels of IL-31 and IL-33 mRNA in the refractory group were higher than those in the initial treatment group. The ST2 mRNA levels in the refractory group and the initial treatment group were higher than that in the control group, but there was no significant difference between the refractory group and the initial treatmentgroup. (4) There was no significant difference between the three groups in the total IgE levels in the peripheral blood. Conclusion IL-31, and IL-33 along with its receptor ST2, may play an important role in the pathogenesis of chronic rhinosinusitis, especially in patients with RRS. Eosinophilic infiltration may also play an important role in the development of RRS.

Key words: Sinusitis, refractory, Receptor ST2, Eosinophils, Interleukin 33, Interleukin 31

CLC Number: 

  • R765.4
[1] 王成硕,张罗. 慢性鼻窦炎的治疗策略[J]. 临床耳鼻咽喉头颈外科杂志,2016,30(14):1175-1178. WANG Chengshuo, ZHANG Luo. Management of chronic rhinosinusitis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(14):1175-1178.
[2] 韩德民. 难治性鼻及鼻窦炎[J]. 中国医学文摘(耳鼻咽喉科学),2010,25(2):59-62. [2017-09-15].
[3] 董革辉,魏培,黄俊琼,等. IL-31单克隆抗体的制备及ELISA检测方法的建立[J]. 中国免疫学杂志,2014,30(4):495-498. DONG Gehui, WEI Pei, HUANG Junqiong, et al. Preparation of monoclonal antibodies against IL-31 and development of sandwich ELISA for IL-31[J].Chin J Immunol, 2014, 30(4):495-498.
[4] Schmitz J, Owyang A, Oldham E, et al. IL-33,an interleukin-l-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]. Immunity, 2005, 23(5):479-490.
[5] Dalm VA, de Wit H, Drexhage HA. Thymosin α 1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis[J]. Ann N Y Acad Sci, 2012, 1270:1-7.
[6] Desrosiers M. Refractory chronic rhinosinusitis: pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery[J]. Curr Allergy Asth Reports, 2004, 4(3):200-207.
[7] Fokkens W,Lund V,Mullol J,et al. European position paper on rhinosinusitis and nasal polyps 2007[J].Rhinol Suppl, 2007, 20: 1-136.
[8] Baumann R, Rabaszowski M, Stenin I, et al. The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms[J]. Clin Transl Allergy, 2012, 2(1):13.
[9] 高雅倩,黄俊琼. 白介素31及其受体在过敏性呼吸道疾病中的作用[J]. 现代医药卫生,2015,31(19):2945-2947.
[10] 刘天聪, 吕昌龙, 曹志伟. IL-33及其受体ST2在伴鼻息肉的慢性鼻-鼻窦炎中的表达及意义[J]. 临床耳鼻咽喉头颈外科杂志, 2015,29(15):1350-1353. LIU Tiancong, LV Changlong, CAO Zhiwei. Expression and role of IL-33and its receptor ST2in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps[J].J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(15):1350-1353.
[11] 郑霞, 邓丹立, 杨辉红. 嗜酸性粒细胞增多与临床[J]. 实用医技杂志, 2008, 15(5): 654-656.
[12] 王节,纪东,桂晓钟. 嗜酸性粒细胞在慢性鼻-鼻窦炎发病中表现的探讨[J]. 中国中西医结合耳鼻咽喉科杂志,2017,25(2):91-93. WANG Jie, JI Dong, GUI Xiaozhong. Study of eosinophils in the pathogenesis of chronic rhinosinusitis[J].Chin J Otorhinolaryngol Integrative Med, 2017, 25(2):91-93.
[1] ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147.
[2] CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50.
[3] ZHANG Jie, NIMA Jizong, XU Xiaodong, ZHOU Jing, LIU Jianmin, LUO Yirui, DU Jintao, BA Luo. Effect of Crocin on Type 2 inflammation in eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 61-67.
[4] LIANG Xu,SHI Li. Research progress in biologic targeted drug therapy for chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 30-35.
[5] YI Ruonan,CHEN Fuquan. Eosinophils and Olfactory Dysfunction [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 50-55.
[6] LIANG Xu, JIN Peng, ZHAO Li, YU Kena, ZI Xiaoxue, YUAN Guangmei, ZANG Yirang, ZHANG Qinqin, ZHANG Hailing, SHI Li, ZHANG Hongping. Role of nasal nitric oxide in diagnosis of chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 181-188.
[7] WAN Xia, KONG Yonggang, CHEN Shiming, HUA Hongli, WEI Yuanyuan, ZENG Manli. Comparison of sinus computed tomography characteristics in patients with eosinophil and non-eosinophil chronic nasosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 275-280.
[8] LI Chunhua, LIU Xiao,LIU Hongbing. Galectin-10 and chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(3): 106-111.
[9] ZHANG Jie, GONG Qi. Clinical significance of eosinophils and neutrophils in blood and allergic reaction in patients with chronic rhinosinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 54-57.
[10] ZHI Lili, SONG Daoliang. Expressions of eosinophils and IL5 in antrochoanal polyps and nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 43-46.
[11] JIN Chengxun, ZHAO Xue, LIU Yue, WEI Ning, JIN Chunshun. Report of 11 cases of Kimuras disease and review of literature. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(6): 63-66.
[12] QIN Jie-sheng1, WANG Hui-ge1, LIN Xin-qiang1, HONG Liang-li2. Expression and significance of IL-15mRNA in nasal polyps [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 34-37.
[13] MENG Qinghua, XIE Jinghua, SU Fang, WANG Lei. Detection of EOS in nasal section of the early stage in patients with allergic rhinitis treated with sublingual specific immunotherapy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(3): 36-39.
[14] LI Shu-jie,YIN Huai-sheng,LV Ling-yan,WU Yu-mei,MENG Ling-qiu,ZHANG Feng,GAO Zhen-feng,CHEN Bing . Esoinophil infiltration on the regeneration of nasal mucosa following nasal endoscopic sinus surgery [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(3): 218-220 .
[15] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 48-50 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd